Skip to content
CancerIndex

Publication

Novel levoglucosenone derivatives: Preclinical evaluation in breast cancer models.

Luciana Cañonero, Aldana M Schey, Lizeth Ariza Bareño, Andrés Bechis, Diego Britez Neira, Florencia Cámpora, Beatriz E Pava Gómez, Ariel M Sarotti, Alejandra G Suárez, María Inés Mangione, Rolando A Spanevello, Marcela Villaverde, María Giselle Peters, Laura B Todaro, Alejandro J Urtreger

European journal of pharmacologyOct 28, 2026PMID 42731650doi:10.1016/j.ejphar.2026.179346 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 30, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260930-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Levoglucosenone is a versatile chiral scaffold that has attracted growing interest for the design of structurally diverse bioactive molecules with potential therapeutic value. In this study, we explored the antitumor activity of three levoglucosenone-based derivatives in preclinical breast cancer…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.